Bridge Therapy Between Induction, ASCT May Slow Neuroblastoma
Three-year event-free survival significantly improved for patients with end-induction stable metastatic disease receiving bridge therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.